Related Experiment Video
Updated: Jan 28, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Glanzmann Thrombasthenia in a Newborn with Heterozygous Factor V Leiden and Heterozygous MTHFR C677T Gene Mutations
Nazli Dilay Gultekin1, Fatma Hilal Yilmaz2, Huseyin Tokgoz3
1Department of Neonatology, Necmettin Erbakan University Meram Medical Faculthy, Konya, Turkey. Correspondence to: Dr Nazli Dilay Gültekin, Department of Neonatology, Necmettin Erbakan University Meram Medical Faculthy, Konya, Turkey. dilayyenihan@hotmail.com.
Introduction:
Glanzmann thrombasthenia is a rare congenital platelet dysfunction.
Case Characteristics:
A 2-day-old male neonate delivered at 35 weeks' gestation was referred with extensive bruising and jaundice. His elder sibling had Glanzmann thrombasthenia, and his mother had thrombophilic risk factors. Flow cytometric analysis revealed absent CD41/CD61. A molecular thrombophilia panel revealed the presence of heterozygous factor V Leiden G1691A and methylenetetrahydrofolate reductase C677T gene mutations.
Outcome:
General precautions to avoid injuries and spontaneous bleeding were advised.
Message:
Life-threatening bleeding may not be the first finding in cases of thrombasthenia accompanied by thrombophilic risk factors.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Transcription Factors
Hardy-Weinberg Principle

